The difference between the wealthiest and poorest income quintiles was 6-3 years in life expectancy and 14-3 in disability free life expectancy for men and 2-8 and 7-6 respectively for women. These results suggest that disparities in health are greater between social groups than between the sexes. Diseases affect mortality and morbidity differently. The order of importance for affecting life expectancy was circulatory disease, cancer, and accidents and for disability free life expectancy, circulatory disease, locomotor disorders, and respiratory disorders.
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Conclusions -Healthy life expectancy is a valuable index for the appreciation of changes in both the physical and the mental health states of the general population, for allocating resources, and for measuring the success of political programmes. Future calculations should also take into account the probability of recovery and thus extend the applicability of the indicator to populations in poor health rather than focusing on the well population. Introduction Healthy life expectancy is an index of a population's state of health derived from estimates of mortality and disability, esentially addressing the question ofwhether observed increases in life expectancy are also accompanied by decreases in morbidity. In other words, are the additional years spent in good health or in a prolonged state of illness and dependency? The question is obviously important both for the understanding of changes in the state of health of a given population and for the formulation ofgovernment policies directed at the provision of services.
Interest in the relation between mortality and morbidity grew out of speculation about the effects of the unpredicted drop in mortality observed in elderly people over the past 15 years. A fundamental question posed by both demographers and epidemiologists was whether this drop was prejudicial to the quality of life-for example, would people who had not died of cardiovascular disease live on in a state of chronic ill health? ' Assumptions from first principles about the effects on a population's health of the decline in mortality reflect differing hypotheses as to its cause. Fries Extreme care should be taken in interpreting the chronological series presently available."' Sullivan's method, which combines mortality quotients (period data) with observed disability prevalence (cohort data, which are a function of the unique history of each generation), provides only an estimation of the value being studied, with unknown precision. Indeed, Sullivan estimated the prevalence at each age for a period (such as a year) by the prevalence observed in each living generation. To constitute a period index capable of attributing a global morbidity characteristic to a given period, disability free life expectancy should be derived only from a combination of period data.
The incidences of entry into disability and recovery are difficult to observe but the probability of survival without disability for both disabled and healthy groups at the beginning of the observation period (such as the beginning of the year) should be easier to measure.
Experimental calculations with these kinds of data have already been made for people aged over 65 in Massachussetts"920 and upper Normandy.2' The upper Normandy study suggests that the additional years of disability observed in women may be explained by the survival differential in favour of women which persists beyond the acquisition of the incapacity,2' a hypothesis reinforced by Manton In the first instance the average duration of life up to the onset of disability could be calculated by using the probabilities of survival without disability, initially for non-disabled people alone. Such an indicator, which totally neglects disabled people, would thus be largely examining preventive health actions. Changes could be interpreted as reflecting fluctuations in the onset of disability hence the efficacy of preventive health programmes. This is clearly a useful application, but the indicator is limited, firstly, in that it inherently assumes that the disability will be permanent and, secondly, in that it focuses on factors related to good health and so applies only to the well population.
A further step would be to calculate additionally the total average duration of life without disability combining the probabilities of survival without disability for people born not disabled with that of subjects born disabled. Change in the arithmetic difference between the two average durations (total average duration of life without disability minus average duration of life up to the onset of the first period of disability) could then be used to describe the relative effectiveness of rehabilitation and therapeutic intervention programmes. In this way an indicator relevant to ill populations may also be derived. With indicators applicable to both healthy and non-healthy people the ethical dilemma of allocating healthy resources only to the well population will be overcome.
Conclusions
Although the well established overall trend in the general population is of diminishing mortality, increases may occasionally be observed for various reasons. Without validated explanatory hypotheses on changes in life expectancy in present demographic projections ana a consensus on its relation to disability, the calculation of chronological series of disability free life expectancy seems to be useful in verifying different theories on the evolution of health states and in forecasting the consequences of a lowering of mortality on the functional health state of particular populations. Estimates of health state under different conditions relating to the evolution of disability (as has already been done for mortality) and more accurate projections of a population's health and resource needs should therefore be possible. Current difficulties in calculating healthy life expectancy as a population indicator relate primarily to a lack of consensus on definitions of health, morbidity, and disability and on the standardisation of calculation procedures. A further limitation lies in the restriction of present calculations to the description of healthy populations. The inclusion of probability of recovery in calculating healthy life expectancy would extend its application to ill populations and hence provide a measure of the efficacy of rehabilitation programmes. It is hoped that the newly constituted international network for the observation of healthy life expectancy will shortly be able to provide guidelines for standardisation of methods to permit crosscultural and intracultural comparisons of changes in state of health.
